These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18809426)

  • 1. Fear memory impairing effects of systemic treatment with the NMDA NR2B subunit antagonist, Ro 25-6981, in mice: attenuation with ageing.
    Mathur P; Graybeal C; Feyder M; Davis MI; Holmes A
    Pharmacol Biochem Behav; 2009 Jan; 91(3):453-60. PubMed ID: 18809426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition.
    Higgins GA; Ballard TM; Huwyler J; Kemp JA; Gill R
    Neuropharmacology; 2003 Mar; 44(3):324-41. PubMed ID: 12604092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition.
    Spooren W; Mombereau C; Maco M; Gill R; Kemp JA; Ozmen L; Nakanishi S; Higgins GA
    Psychopharmacology (Berl); 2004 Aug; 175(1):99-105. PubMed ID: 14985927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
    Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
    J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory.
    Zhao MG; Toyoda H; Lee YS; Wu LJ; Ko SW; Zhang XH; Jia Y; Shum F; Xu H; Li BM; Kaang BK; Zhuo M
    Neuron; 2005 Sep; 47(6):859-72. PubMed ID: 16157280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NR2B subunit-specific NMDA antagonist Ro25-6981 inhibits the expression of conditioned fear: a comparison with the NMDA antagonist MK-801 and fluoxetine.
    Haller J; Nagy R; Toth M; Pelczer KG; Mikics E
    Behav Pharmacol; 2011 Apr; 22(2):113-21. PubMed ID: 21285873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning.
    Rodrigues SM; Schafe GE; LeDoux JE
    J Neurosci; 2001 Sep; 21(17):6889-96. PubMed ID: 11517276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.
    Higgins GA; Ballard TM; Enderlin M; Haman M; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):85-98. PubMed ID: 15759152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic, pharmacological and lesion analyses reveal a selective role for corticohippocampal GLUN2B in a novel repeated swim stress paradigm.
    Kiselycznyk C; Svenningsson P; Delpire E; Holmes A
    Neuroscience; 2011 Oct; 193():259-68. PubMed ID: 21704131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.
    Boyce S; Wyatt A; Webb JK; O'Donnell R; Mason G; Rigby M; Sirinathsinghji D; Hill RG; Rupniak NM
    Neuropharmacology; 1999 May; 38(5):611-23. PubMed ID: 10340299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NR2A-Containing NMDARs in the Prefrontal Cortex Are Required for Working Memory and Associated with Age-Related Cognitive Decline.
    McQuail JA; Beas BS; Kelly KB; Simpson KL; Frazier CJ; Setlow B; Bizon JL
    J Neurosci; 2016 Dec; 36(50):12537-12548. PubMed ID: 27807032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-acquisition hippocampal blockade of the NMDA receptor subunit GluN2A but not GluN2B sustains spatial reference memory retention.
    Shinohara K; Hata T
    Neurobiol Learn Mem; 2018 Jan; 147():1-8. PubMed ID: 29127002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the GluN2B-NMDA receptor antagonist Ro 25-6981 on two types of behavioral flexibility in rats.
    Clark E; Antoniak K; Feniquito A; Dringenberg HC
    Behav Brain Res; 2017 Feb; 319():225-233. PubMed ID: 27871866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid.
    Fantin M; Morari M; Tison F; Fernagut PO
    Neurol Res; 2011 May; 33(4):444-7. PubMed ID: 21535946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoflurane/nitrous oxide anesthesia induces increases in NMDA receptor subunit NR2B protein expression in the aged rat brain.
    Mawhinney LJ; de Rivero Vaccari JP; Alonso OF; Jimenez CA; Furones C; Moreno WJ; Lewis MC; Dietrich WD; Bramlett HM
    Brain Res; 2012 Jan; 1431():23-34. PubMed ID: 22137658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J; Rajakumar N
    Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of conditioned freezing to tone, but not to context, in Fyn-transgenic mice: relationship to NMDA receptor subunit 2B function.
    Kojima N; Sakamoto T; Endo S; Niki H
    Eur J Neurosci; 2005 Mar; 21(5):1359-69. PubMed ID: 15813945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal NR2B-containing NMDA receptors enhance long-term potentiation in rats with chronic visceral pain.
    Chen Y; Chen AQ; Luo XQ; Guo LX; Tang Y; Bao CJ; Lin L; Lin C
    Brain Res; 2014 Jun; 1570():43-53. PubMed ID: 24824341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala.
    Sotres-Bayon F; Bush DE; LeDoux JE
    Neuropsychopharmacology; 2007 Sep; 32(9):1929-40. PubMed ID: 17213844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.
    Hanson JE; Pare JF; Deng L; Smith Y; Zhou Q
    Neurobiol Dis; 2015 Feb; 74():254-62. PubMed ID: 25484285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.